← Back
$RCUS All transactions

Arcus Biosciences, Inc.

▼ SELL

$ Value

$100K

Shares

4,494

Price

$22

Filed

Dec 18

Insider

Name

Markus Richard

Title

Chief Medical Officer

CIK

0002056093

Roles

Officer

Transaction Details

Transaction Date

2025-12-17

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

65,647

Footnotes

Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | Includes the unvested portion of the reporting person's RSU grants. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Filing Info

Accession No.

0002056093-25-000005

Form Type

4

Issuer CIK

0001724521

Markus Richard's History

Date Ticker Type Value
2026-01-23 RCUS A $0
2026-01-23 RCUS A $0
2025-12-17 RCUS $100K
2025-12-16 RCUS $111K

Other Insiders at RCUS (90d)

Insider Bought Sold Last
ROSEN TERRY J
Chief Executive Officer
2026-01-23
Jaen Juan C.
President
2026-01-23
Goeltz II Robert C.
Chief Financial Officer
2026-01-23
Jarrett Jennifer
Chief Operating Officer
2026-01-23
Azoy Alexander
Chief Accounting Officer
2026-01-23
Tang Carolyn C.
General Counsel
2026-01-23
Markus Richard
Chief Medical Officer
2026-01-23